Overview
Nassar Khan is a Hematologist and a Hematologist Oncology provider in Fairfax, Virginia. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Lung Adenocarcinoma. Dr. Khan is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10701 Main St, Fairfax, VA 22030
Mgmc LLC
Craig Kessler is a Hematologist in Washington, Washington, D.c.. Dr. Kessler is rated as an Elite provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Blood Clots, Hemophilia A, Acquired Hemophilia, Bone Marrow Aspiration, and Splenectomy.
The Center For Cancer & Blood Disorders
Dr. Ralph V. Boccia is a hematologist affiliated with Sibley Memorial Hospital, Suburban Hospital, Shady Grove Adventist Hospital, Holy Cross Hospital and MedStar Georgetown University Hospital, where he is a clinical associate professor of medicine for the University, as well as the medical director of the International Oncology Network (ION) Clinical Research Program and the chairman of ION’s Medical Advisory Panel. He practices out of the Center for Cancer and Blood Disorders, of which he is the founder and medical director, located in Bethesda, Maryland and Germantown, Maryland. Dr. Boccia earned his medical degree from the Autonomous University of Guadalajara School of Medicine. He completed a residency in internal medicine at Kern Medical Center, followed by a fellowship in hematology, oncology and bone marrow transplant at the combined UCLA-Veterans Administration Program and The National Cancer Institute at the National Institutes of Health. Dr. Boccia is a member of the American College of Physicians, the American Society of Clinical Oncology, the American Society of Hematology and the American Society for Blood and Marrow Transplantation. Dr. Boccia has been listed as a Top Doctor by Washingtonian Magazine and Consumers’ Checkbook Magazine since 1992. He has also been recognized as a Super Doctor by The Washington Post Magazine and a Regional Top Doctor for Washington, D.C., Baltimore and Washington-Baltimore by Castle Connolly. Dr. Boccia has contributed to various articles with his research, published in journals such as Annals of Internal Medicine, Journal of Clinical Oncology and The Lancet. Recent News Articles and Media Coverage Bladder cancer trends in Montgomery and Prince George's counties: Welcome news - and 3 facts you need to know. NJ.com (08/16/2016) RCCA Expands to Maryland to Become One of the Nation's First Multi-State Oncology/Hematology Physician-Owned and -Operated Networks. OncLive (10/06/2015). Dr. Boccia is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Anemia, Multiple Myeloma, Thrombocytopenia, Adult Immune Thrombocytopenia, and Splenectomy.
Mgmc LLC
Catherine Broome is a Hematologist in Washington, Washington, D.c.. Dr. Broome is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Autoimmune Hemolytic Anemia, Chronic B-Cell Leukemia (CBCL), Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Khan isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung AdenocarcinomaDr. Khan isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Khan isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Khan isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Khan isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Khan isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Deep Vein ThrombosisDr. Khan isAdvanced. Learn about Deep Vein Thrombosis.
- EGFR Positive Lung CancerDr. Khan isAdvanced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Khan isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung CancerDr. Khan isAdvanced. Learn about Lung Cancer.
- Experienced
- Acute Mountain SicknessDr. Khan isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Adult Immune ThrombocytopeniaDr. Khan isExperienced. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Khan isExperienced. Learn about Anemia.
- AngiosarcomaDr. Khan isExperienced. Learn about Angiosarcoma.
- Aplastic AnemiaDr. Khan isExperienced. Learn about Aplastic Anemia.